Abstract

Abstract: In the evolving landscape of clinical trials, wearable technologies are revolutionizing the monitoring and prediction of pharmacokinetic variations. This study explores how wearable devices, such as smartwatches and biosensors, are utilized to collect real-time physiological data that enhances the understanding of drug metabolism and response. By integrating wearable technology into clinical trials, researchers can achieve continuous monitoring of key biomarkers, assess patient adherence, and gain insights into individual pharmacokinetic profiles. This approach not only improves the accuracy of pharmacokinetic modeling but also facilitates personalized medicine by allowing for adaptive dosing and intervention strategies. The paper reviews recent advancements in wearable technology, evaluates their impact on pharmacokinetic research, and discusses future directions for integrating these tools into clinical trial protocols